Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for

G W Demers1, E Espling, J B Harry

  • 1Program in Cancer Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98040, USA.

Journal of Virology
|October 1, 1996
PubMed

Insights

Human papillomavirus (HPV) E7 oncogenes disrupt cell cycle arrest signals, promoting cell proliferation and contributing to cancer. Mutated E7 proteins that bind retinoblastoma protein are key to this effect.

Area of Science:

  • Cell Biology
  • Virology
  • Molecular Biology

Background:

  • Cells normally arrest in G1/G0 phase due to negative growth signals.
  • Human papillomavirus (HPV) oncogenes may overcome these signals, contributing to neoplastic potential.
  • Understanding how viral proteins affect cell cycle regulation is crucial.

Purpose of the Study:

  • To investigate the ability of HPV oncogenes, specifically E7 and E6 proteins, to bypass distinct negative growth arrest signals in epithelial cells.
  • To determine the role of retinoblastoma protein binding in the function of HPV E7.
  • To compare the effects of high-risk (HPV-16) and low-risk (HPV-6) HPV proteins on cell cycle control.

Main Methods:

  • Assessing the ability of HPV-16 E7 and E6 proteins to abrogate specific cell cycle arrest signals (suprabasal quiescence, DNA damage-induced G1 arrest, TGF-β-induced arrest).
  • Utilizing mutated E7 proteins to identify critical functional domains, including retinoblastoma protein binding.
  • Comparing the effects of HPV-16 proteins with those of HPV-6 proteins.

Main Results:

  • HPV-16 E7 abrogated all three tested negative growth arrest signals.
  • Mutant E7 proteins unable to abrogate growth arrest, including those that did not bind retinoblastoma protein, were transformation deficient.
  • HPV-16 E6 only bypassed DNA damage-induced G1 arrest.
  • HPV-6 E6 and E7 proteins did not bypass any of the tested growth arrest signals.

Conclusions:

  • The E7 protein of high-risk HPV-16 plays a significant role in disrupting multiple cell cycle checkpoints, likely contributing to its oncogenic potential.
  • Retinoblastoma protein binding is essential for the ability of HPV-16 E7 to abrogate growth arrest signals.
  • Low-risk HPV-6 proteins lack the ability to significantly interfere with these cellular growth control mechanisms.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...